JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage
Johnson & Johnson (NYSE: JNJ) is trading through a holiday-shortened Christmas Eve session with investors balancing a familiar mix of defensive appeal and headline risk. On Wednesday, December 24, 2025, J&J shares hovered around $207 in late-morning trade, keeping the healthcare bellwether close to its recent highs even as the company faces fresh legal scrutiny and renewed policy pressure on U.S. drug pricing. [1]
The immediate backdrop matters: U.S. markets are closing early at 1 p.m. ET for Christmas Eve, a schedule that can amplify moves and distort volume signals—especially for mega-caps like J&J that often act as “parking spots” for cautious capital. [2]
Below is what’s driving JNJ stock today (24.12.2025)—and what…
